Fig. 2From: Psychometric validation of the Pyruvate Kinase Deficiency Diary and Pyruvate Kinase Deficiency Impact Assessment in adults in the phase 3 ACTIVATE trialInter-item Spearman correlation matrices for PKDD (a, b) and PKDIA (c, d) items at baseline. For the PKDD, the scoring values for Items 6 and 7 were inverted for consistency, to ensure that higher scores represented greater disease burden for all items. PKDD Pyruvate Kinase Deficiency Diary, PKDIA Pyruvate Kinase Deficiency Impact AssessmentBack to article page